Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Milestone Pharmaceuticals Inc. | mist-20191231ex321109f9d.htm |
| EX-31.2 - EX-31.2 - Milestone Pharmaceuticals Inc. | mist-20191231ex312dee1ff.htm |
| EX-31.1 - EX-31.1 - Milestone Pharmaceuticals Inc. | mist-20191231ex31162aca5.htm |
| EX-4.3 - EX-4.3 - Milestone Pharmaceuticals Inc. | mist-20191231ex43a48f010.htm |
| 10-K - 10-K - Milestone Pharmaceuticals Inc. | mist-20191231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-231347) of Milestone Pharmaceuticals Inc. of our report dated March 5, 2020 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP1
Montréal, Québec, Canada
March 5, 2020
1 CPA auditor, CA, public accountancy permit No. A113048